Src Like Adaptor 2 (SLA2) is a protein encoded by the SLA2 gene and is a member of the Src like adaptor family. SLA2 functions as an important component in the regulation of immune cell signaling. It is specifically involved in T-cell receptor (TCR) signaling and has been shown to modulate the activity of various other receptors on immune cells, such as the B-cell receptor (BCR).As an adaptor protein, SLA2 does not possess intrinsic enzymatic activity but instead facilitates signal transduction by mediating protein-protein interactions. It contains several domains characteristic of adaptor proteins, including SH2 (Src Homology 2) and SH3 (Src Homology 3) domains. These domains allow SLA2 to bind to phosphorylated tyrosine residues and proline-rich motifs in other signaling proteins, respectively. Through these interactions, SLA2 can negatively regulate signaling pathways initiated by receptors on the surface of lymphocytes, thus serving as a checkpoint for preventing overactivation of immune responses.
The protein's role in immune regulation makes it a potential candidate for involvement in autoimmune diseases and immunodeficiencies. Alterations in the expression or function of SLA2 can lead to aberrant immune responses, which further underscores its significance in maintaining immune homeostasis.Research into SLA2 has expanded our understanding of the molecular mechanisms governing T-cell activation and tolerance. By controlling the threshold of T-cell receptor signaling, SLA2 ensures that T-cells are activated only under appropriate physiological conditions, preventing unintended immune activation that could result in tissue damage or autoimmune disease.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate proteins involved in T-cell activation, potentially enhancing SLA2 signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which could activate calcium-dependent kinases affecting SLA2 function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP, activating PKA which may phosphorylate substrates relevant to SLA2's pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, shifting the equilibrium in MAPK signaling which may indirectly increase SLA2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, altering signaling pathways and potentially increasing SLA2-mediated signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which can affect MAPK pathway components, potentially enhancing SLA2 function. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB203580 inhibits p38 MAPK, which may shift signaling to favor pathways involving SLA2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can alter downstream signaling, potentially augmenting SLA2 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which may result in altered signaling that enhances SLA2 function. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C inhibits PKC, and its regulatory role may indirectly lead to the enhancement of SLA2 signaling. | ||||||